Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ Management Team

Mr. Stephen Hurly

President

Chief Executive Officer

Management Director

Age 53

Compensation $746.9K USD

Sex Male

Dr. Paul Parren

Executive Vice President Head of Research and Development

Age 57

Compensation -

Sex Male

Mr. Hans Van Der Vliet

Chief Scientific Officer

Age 48

Compensation -

Sex Male

Ms. Amy Garabedian

General Counsel

Corporate Secretary

Age 46

Compensation -

Sex Female

Mr. Ton Adang

Chief Development Officer

Age 60

Compensation -

Sex Male

Mr. Benjamin Winograd

Chief Medical Officer

Age 65

Compensation -

Sex Male

Mr. Edward Smith

Chief Financial Officer

Age 52

Compensation -

Sex Male

Dr. Kapil Dhingra

Non-Executive Chairman of the Board

Age 65

Compensation $54.75K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Stephen Hurly President Chief Executive Officer Management Director	53	$746.9K USD	Male
Dr. Paul Parren Executive Vice President Head of Research and Development	57	-	Male
Mr. Hans Van Der Vliet Chief Scientific Officer	48	-	Male
Ms. Amy Garabedian General Counsel Corporate Secretary	46	-	Female
Mr. Ton Adang Chief Development Officer	60	-	Male
Mr. Benjamin Winograd Chief Medical Officer	65	-	Male
Mr. Edward Smith Chief Financial Officer	52	-	Male
Dr. Kapil Dhingra Non-Executive Chairman of the Board	65	$54.75K USD	Male

Board of Directors

From the proxy statement filed Apr 28, 2025

Directors

serving now

Independent

7 of 7

stated in the proxy; 1 not stated

Average tenure

3.2 years

from year joined

CEO also chairs the board

Kapil Dhingra

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Kapil Dhingra Board chair	65	2021 4 years	Independent	None stated	None stated	$112,836
Stephen Hurly CEO	57	2019 6 years	Not stated	None stated	None stated	Paid as CEO
Jay T. Backstrom	70	2022 3 years	Independent	Nomination and Corporate Governance Committee	Be Biopharma	$89,836
Peter A. Kiener	72	2023 2 years	Independent	None stated	Wugen, Inc.	$80,836
James J. Noble	65	2022 3 years	Independent	None stated	Orexo AB	$93,336
Christy J. Oliger	55	2023 2 years	Independent	Audit Committee	Karyopharm Therapeutics	$90,336
Mary E. Wadlinger	65	2023 2 years	Independent	Compensation Committee	None stated	$83,836
Karen J. Wilson	61	2021 4 years	Independent	None stated	Elicio Therapeutics	$95,836

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 28, 2025

all of our directors

current and former directors

Amount not stated

Indemnification agreements entered into with all of our directors

Open in proxy

Comments

Company Executives

$ Management Team

Mr. Stephen Hurly

Dr. Paul Parren

Mr. Hans Van Der Vliet

Ms. Amy Garabedian

Mr. Ton Adang

Mr. Benjamin Winograd

Mr. Edward Smith

Dr. Kapil Dhingra

Board of Directors

Related-party transactions